Skip to content
Tech News
clear
Topics: Today This Week This Month This Year
91.
Novo Nordisk Abruptly Ends Partnership with Hims, Claiming ‘Sham Compounding’ GLP-1 Drugs (gizmodo.com)
92.
Eli Lilly’s Obesity Pill Appears to Work as Well as Injected GLP-1s (wired.com)
93.
Surgery Still Beats Ozempic and Other GLP-1 Drugs in Real-World Weight Loss Study (gizmodo.com)
94.
Threat in Your Medicine Cabinet: The FDA's Gamble on America's Drugs (news.ycombinator.com)
95.
Doctors Concerned By Massive Uptick In Teens Taking Ozempic (futurism.com)
96.
Shares of Hims & Hers tumble 26% after FDA says semaglutide is no longer in shortage (cnbc.com)
Today's top topics: openai google tesla cybersecurity apple artemis ii anthropic meta artificial intelligence microsoft
View all today's topics →